InvestorsHub Logo
Followers 24
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: misiu143 post# 155025

Friday, 03/26/2021 8:16:50 PM

Friday, March 26, 2021 8:16:50 PM

Post# of 233759

It is written everyplace what may happen when we suppress GM-CSF , this is not a secret ..

What might be a reason that all patients with secondary viral , bacterial , fungi infection are excluded from the study ..


It is true with otilimab. The Mayo Clinic says it is not true with lenzilumab. I can find you a plethora of quotes from the Mayo Clinic talking about how lenz has good safety. Show me one that says otherwise specifically about lenz. The other anti-GM-CSF drugs having safety issues is good for lenz because the other anti-GM-CSF drugs could eventually become real competition.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News